Physician profile
Albert Cheng
NPI 1265056469
$668.89
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.53 · 2021: $233 · 2022: $233 · 2023: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $142.77 | 2021-2023 | Eliquis |
| Novo Nordisk INC | $119.45 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $115.80 | 2021 | |
| Abbvie INC. | $68.26 | 2022-2023 | Dalvance |
| Pfizer INC. | $44.85 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $36.94 | 2020 | |
| Edwards Lifesciences Corporation | $30.74 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.38 | 2022 | |
| Amgen INC. | $23.64 | 2021 | |
| Fresenius USA Marketing, INC. | $16.65 | 2021 | |
| La Jolla Pharmaceutical Company | $16.09 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.73 | 2022 | |
| Merck Sharp & Dohme LLC | $13.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.